315PHARMACOVIGILANCE IN PEDIATRIC POPULATIONS: A COMPREHENSIVE REVIEW OF OPPORTUNITIES AND CHALLENGESOne of the most important aspects of pharmacovigilance is its application to Pediatric populations, where it is used to monitor, assess, and enhance children's pharmaceutical safety and efficacy. Pediatric patients have different medication absorption, distribution, metabolism, and excretion processes because of their specific physiological characteristics. Because performing research on children may be challenging and raise ethical problems, there is frequently a lack of representation of children in clinical trials. When Pediatric pharmacovigilance is done well, medications are administered safely to children from birth to adolescence. To raise the bar for medication safety and safeguard children's health, cooperation between researchers, pharmaceutical firms, regulatory bodies, and healthcare professionals is crucial. Establishing legal frameworks, creating pediatric-specific protocols, managing and collecting data, implementing active surveillance systems, working with international partners, providing training and education, conducting research and development, taking ethical issues into account, and utilizing technology are all part of pharmacovigilance in paediatric populations. It will take focused efforts from regulatory bodies, healthcare providers, and researchers to address issues like limited data, extrapolating adult data, ethical concerns, variability across age groups, under-reporting of adverse drug reactions, dosage form issues, regulatory challenges, and lack of incentives for pharmaceutical companiesyamayur@gmail.comResearch1412024Pharmacovigilance, Peadiatric, Metabolism, Healthcare, DrugDr. Mayur Rasiklal YadaIndependent Researcher